The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Monogenetic Disorders Testing-Global Market Insights and Sales Trends 2024
Synopsis
According to Mendel's Laws, the monogenetic disorders are inherited because of a single defective gene on the autosomes. The monogenic disorders are caused by single mutated gene which can be present on single or both chromosomes. Females and males are equally affected by this disorder due to the conditions on the autosomes. Some of the tests are available for the mainstream of the common monogenic disorders such as Cystic fibrosis, sickle cell anemia, SCID, Tay-sachs disease, polycystic kidney disorder, Gaucher's disease, Huntington's disease, neurofibromatosis, thalassaemia and familial hypercholesterolemia. There are several test performed to treat with the monogenic disorders such as diagnostic testing, carrier testing, predictive & pre-symptomatic testing, prenatal testing and new-born screening.
The global Monogenetic Disorders Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Monogenetic Disorders Testing in various end use industries. The expanding demands from the Hospitals, Specialized Clinics and Ambulatory Surgical Centers,, are propelling Monogenetic Disorders Testing market. Carrier Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diagnostic Testing segment is estimated at % CAGR for the next seven-year period.
North America clearly dominates the global monogenetic disorders testing market due to high degree of intelligence and awareness regarding to the monogenic disorders testing procedures. The companies are focused on introducing the procedures with innovative technology, Europe is expected to hold the second large market followed by Asia-Pacific region.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Monogenetic Disorders Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Monogenetic Disorders Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Monogenetic Disorders Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Monogenetic Disorders Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Monogenetic Disorders Testing covered in this report include Celera Group, Abbott, Thermo Fisher Scientific, ELITech Group, Quest, AutoGenomics, PerkinElmer, Roche and Bio-Rad, etc.
The global Monogenetic Disorders Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Celera Group
Abbott
Thermo Fisher Scientific
ELITech Group
Quest
AutoGenomics
PerkinElmer
Roche
Bio-Rad
Transgenomic
Global Monogenetic Disorders Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Monogenetic Disorders Testing market, Segment by Type:
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive & Pre-Symptomatic Testing
Prenatal Testing
Others
Global Monogenetic Disorders Testing market, by Application
Hospitals
Specialized Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Monogenetic Disorders Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
According to Mendel's Laws, the monogenetic disorders are inherited because of a single defective gene on the autosomes. The monogenic disorders are caused by single mutated gene which can be present on single or both chromosomes. Females and males are equally affected by this disorder due to the conditions on the autosomes. Some of the tests are available for the mainstream of the common monogenic disorders such as Cystic fibrosis, sickle cell anemia, SCID, Tay-sachs disease, polycystic kidney disorder, Gaucher's disease, Huntington's disease, neurofibromatosis, thalassaemia and familial hypercholesterolemia. There are several test performed to treat with the monogenic disorders such as diagnostic testing, carrier testing, predictive & pre-symptomatic testing, prenatal testing and new-born screening.
The global Monogenetic Disorders Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Monogenetic Disorders Testing in various end use industries. The expanding demands from the Hospitals, Specialized Clinics and Ambulatory Surgical Centers,, are propelling Monogenetic Disorders Testing market. Carrier Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diagnostic Testing segment is estimated at % CAGR for the next seven-year period.
North America clearly dominates the global monogenetic disorders testing market due to high degree of intelligence and awareness regarding to the monogenic disorders testing procedures. The companies are focused on introducing the procedures with innovative technology, Europe is expected to hold the second large market followed by Asia-Pacific region.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Monogenetic Disorders Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Monogenetic Disorders Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Monogenetic Disorders Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Monogenetic Disorders Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Monogenetic Disorders Testing covered in this report include Celera Group, Abbott, Thermo Fisher Scientific, ELITech Group, Quest, AutoGenomics, PerkinElmer, Roche and Bio-Rad, etc.
The global Monogenetic Disorders Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Celera Group
Abbott
Thermo Fisher Scientific
ELITech Group
Quest
AutoGenomics
PerkinElmer
Roche
Bio-Rad
Transgenomic
Global Monogenetic Disorders Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Monogenetic Disorders Testing market, Segment by Type:
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive & Pre-Symptomatic Testing
Prenatal Testing
Others
Global Monogenetic Disorders Testing market, by Application
Hospitals
Specialized Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Monogenetic Disorders Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Monogenetic Disorders Testing
1.1 Monogenetic Disorders Testing Market Overview
1.1.1 Monogenetic Disorders Testing Product Scope
1.1.2 Monogenetic Disorders Testing Market Status and Outlook
1.2 Global Monogenetic Disorders Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Monogenetic Disorders Testing Market Size by Region (2018-2029)
1.4 Global Monogenetic Disorders Testing Historic Market Size by Region (2018-2023)
1.5 Global Monogenetic Disorders Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Monogenetic Disorders Testing Market Size (2018-2029)
1.6.1 North America Monogenetic Disorders Testing Market Size (2018-2029)
1.6.2 Europe Monogenetic Disorders Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Monogenetic Disorders Testing Market Size (2018-2029)
1.6.4 Latin America Monogenetic Disorders Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Monogenetic Disorders Testing Market Size (2018-2029)
2 Monogenetic Disorders Testing Market by Type
2.1 Introduction
2.1.1 Carrier Testing
2.1.2 Diagnostic Testing
2.1.3 New-Born Screening
2.1.4 Predictive & Pre-Symptomatic Testing
2.1.5 Prenatal Testing
2.1.6 Others
2.2 Global Monogenetic Disorders Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Monogenetic Disorders Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Monogenetic Disorders Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Monogenetic Disorders Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Monogenetic Disorders Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Monogenetic Disorders Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Monogenetic Disorders Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Monogenetic Disorders Testing Revenue Breakdown by Type (2018-2029)
3 Monogenetic Disorders Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Specialized Clinics
3.1.3 Ambulatory Surgical Centers
3.2 Global Monogenetic Disorders Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Monogenetic Disorders Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Monogenetic Disorders Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Monogenetic Disorders Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Monogenetic Disorders Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Monogenetic Disorders Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Monogenetic Disorders Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Monogenetic Disorders Testing Revenue Breakdown by Application (2018-2029)
4 Monogenetic Disorders Testing Competition Analysis by Players
4.1 Global Monogenetic Disorders Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monogenetic Disorders Testing as of 2022)
4.3 Date of Key Players Enter into Monogenetic Disorders Testing Market
4.4 Global Top Players Monogenetic Disorders Testing Headquarters and Area Served
4.5 Key Players Monogenetic Disorders Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Monogenetic Disorders Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Celera Group
5.1.1 Celera Group Profile
5.1.2 Celera Group Main Business
5.1.3 Celera Group Monogenetic Disorders Testing Products, Services and Solutions
5.1.4 Celera Group Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Celera Group Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Monogenetic Disorders Testing Products, Services and Solutions
5.2.4 Abbott Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Profile
5.3.2 Thermo Fisher Scientific Main Business
5.3.3 Thermo Fisher Scientific Monogenetic Disorders Testing Products, Services and Solutions
5.3.4 Thermo Fisher Scientific Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.3.5 ELITech Group Recent Developments
5.4 ELITech Group
5.4.1 ELITech Group Profile
5.4.2 ELITech Group Main Business
5.4.3 ELITech Group Monogenetic Disorders Testing Products, Services and Solutions
5.4.4 ELITech Group Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.4.5 ELITech Group Recent Developments
5.5 Quest
5.5.1 Quest Profile
5.5.2 Quest Main Business
5.5.3 Quest Monogenetic Disorders Testing Products, Services and Solutions
5.5.4 Quest Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Quest Recent Developments
5.6 AutoGenomics
5.6.1 AutoGenomics Profile
5.6.2 AutoGenomics Main Business
5.6.3 AutoGenomics Monogenetic Disorders Testing Products, Services and Solutions
5.6.4 AutoGenomics Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.6.5 AutoGenomics Recent Developments
5.7 PerkinElmer
5.7.1 PerkinElmer Profile
5.7.2 PerkinElmer Main Business
5.7.3 PerkinElmer Monogenetic Disorders Testing Products, Services and Solutions
5.7.4 PerkinElmer Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.7.5 PerkinElmer Recent Developments
5.8 Roche
5.8.1 Roche Profile
5.8.2 Roche Main Business
5.8.3 Roche Monogenetic Disorders Testing Products, Services and Solutions
5.8.4 Roche Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Roche Recent Developments
5.9 Bio-Rad
5.9.1 Bio-Rad Profile
5.9.2 Bio-Rad Main Business
5.9.3 Bio-Rad Monogenetic Disorders Testing Products, Services and Solutions
5.9.4 Bio-Rad Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Bio-Rad Recent Developments
5.10 Transgenomic
5.10.1 Transgenomic Profile
5.10.2 Transgenomic Main Business
5.10.3 Transgenomic Monogenetic Disorders Testing Products, Services and Solutions
5.10.4 Transgenomic Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Transgenomic Recent Developments
6 North America
6.1 North America Monogenetic Disorders Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Monogenetic Disorders Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Monogenetic Disorders Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Monogenetic Disorders Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Monogenetic Disorders Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Monogenetic Disorders Testing Market Dynamics
11.1 Monogenetic Disorders Testing Industry Trends
11.2 Monogenetic Disorders Testing Market Drivers
11.3 Monogenetic Disorders Testing Market Challenges
11.4 Monogenetic Disorders Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
